LL-37 is the sole human cathelicidin—a 37-amino-acid cationic peptide named for two N-terminal leucines and chain length. It is produced by neutrophils, macrophages, and epithelial cells of skin, lung, and gut—where the body meets pathogens directly. The primary antimicrobial mechanism is electrostatic: the molecule’s net +6 charge attracts negatively charged bacterial membranes; the peptide inserts, forms transmembrane pores, and lyses the cell. Coverage spans Gram-positive and Gram-negative bacteria, fungi, and several viruses, including enveloped types.
Beyond direct pathogen killing, LL-37 coordinates immunity: it neutralizes bacterial LPS, limiting excessive endotoxin response, and chemoattracts neutrophils, monocytes, mast cells, and T lymphocytes to the infection site. It activates epithelial cells via the MAPK/ERK pathway, increasing IL-8 and driving proliferative and migratory responses—making it both defensive and regenerative for barrier tissues. Antibiofilm activity stands out separately: LL-37 disrupts mature S. aureus and P. aeruginosa biofilms and prevents formation—a mechanism often resistant to standard antibiotics in chronic infection.
LL-37’s immunomodulatory role is dual and context-dependent: at physiological concentrations it lowers TLR4-dependent inflammation and IL-10, while at high concentrations or in certain microenvironments it can amplify pro-inflammatory signals and type I IFN. Use therefore requires understanding inflammatory context and baseline immune status. Potential in oncology (immune activation in solid tumors) and chronic skin conditions (atopic dermatitis, psoriasis) is under active study.
🛡️ Antimicrobial spectrum (bacteria, fungi, viruses): ★★★★★
🔥 Immune coordination and chemotaxis: ★★★★☆
🧬 Antibiofilm activity: ★★★★★
✅ Safety: ★★★☆☆ (dual immune profile requires context assessment)
⚠️ Possible sensations and side effects: possible flare in inflammatory states; systemic use warrants caution
🤝 Combinations (goal → stack)
🛡️ Immune defense + infection → LL-37 + Thymosin Alpha 1
🧬 Chronic infection + biofilm → LL-37 + KPV
🫁 Respiratory protection → LL-37 + Bronchogen
| CAS number | 154947-66-7 |
| Batch purity | 99.49 % |
Full details in our guide
https://peptideboost.club/guide/ll-37Dear customers
We are pleased to offer you high-quality peptide products for research purposes within laboratory experiments. Any introduction of these products into the human or animal body is strictly prohibited.
Before purchasing, please carefully read our terms.
We guarantee the quality, purity, and conformity to the description of the products we provide, but their use should only be carried out by qualified specialists with the necessary knowledge and equipment for safe handling.
Our products are not intended for use as dietary supplements, medicines, food products, or cosmetics. Peptide Boost products should not be mislabeled, used, or designated as such. Purpose and use are strictly limited to scientific research.
Information on our website is for educational and informational purposes only. We make no claims about the ability to treat or prevent diseases with our products.
Thank you for your understanding and we wish you success!
Any questions left?
Leave your email and we will definitely call you back to advise you on the product